Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …

In recent years, there is growing evidence of associations between antibodies against
myelin oligodendrocyte glycoprotein (MOG) and several phenotypes of acute inflammatory …

Background: Neuromyelitis optic spectrum disorder (NMOSD) is a rare demyelinating,
autoimmune disease and the burden in United States is not well characterized. Objective …

This study aimed to identify the prevalence, clinical and radiographic characteristics, and
risk factors for cognitive dysfunction in patients with Neuromyelitis optica spectrum disorder …

Demyelination is a pathological feature commonly observed in various central nervous
system diseases. It is characterized by the aggregation of oligodendrocyte progenitor cells …

Objectives To report myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) epidemiology in two American regions using 2023 diagnostic criteria. Patients …

Abstract Purpose The Italian Island of Sardinia (population, 1,578,146) is recognized for the
high risk of multiple sclerosis (MS) but the epidemiological burden of other less common …

Background Despite the global availability of multiple sclerosis (MS) treatments, accessing
and financing them in Southeast Asia (SEA) remains a challenge. This descriptive survey …

Over the last two decades, the spectrum of neurologic disorders associated with specific
autoantibody biomarkers have expanded. These autoimmune disorders may affect both the …

Objective: The effects of immunotherapies on the immune response to various regimens of
SARS-CoV-2 vaccines in patients with autoimmune neurological disease have been …